ISAAC Trial – Invasive Strep A: Defining the Role of Antibiotic Prophylaxis in Contact Management

CONDITION

Infection

GENDER

All

AGE GROUP

From 0

and above

STATUS

Recruiting

In the ISAAC trial, household contacts of iGAS (Invasive Group A Strep) cases will be invited to participate in the study. People who take part will be randomised to receive either: no antibiotics, a beta-lactam antibiotic or azithromycin. Participants will be asked to take throat swabs at baseline and day 14 to test for secondary iGAS.

Studies Contact Form

Approved By: Royal Melbourne Hospital HREC              

Clinical Trial Registry Link: Click Here


Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260